Titlebook: Recombinant Antibodies for Cancer Therapy; Methods and Protocol Martin Welschof,Jürgen Krauss Book 2003 Humana Press 2003

脫毛

窩轉(zhuǎn)脊椎動(dòng)物

使隔離

Tailoring Kinetics of Antibodies Using Focused Combinatorial Librariesof binding virtually any molecule including proteins, carbohydrates, nucleic acids, and haptens. The intrinsic features of specificity and affinity when combined offer a great advantage in the discovery of a wide-range of lead drug candidates.

高貴領(lǐng)導(dǎo)

Humanization of Monoclonal Antibodies by CDR GraftingThe discovery of the process for making rodent monoclonal antibodies (MAbs) 26 years ago by Kohler and Milstein has led to a revolution in the treatment of over 50 major diseases, and has borne an industry whose products today represent 6% of total biotechnology sales. The full potential of this industry has still to be reached.

和平

Recombinant Single-Chain and Disulfide-Stabilized Fv Immunotoxins for Cancer TherapyThe rapid progress in understanding the molecular biology of cancer cells has made a large impact on the design and development of novel therapeutic strategies.

Amnesty

使迷惑

Aggregate

Recombinant Antibodies for Cancer Therapy978-1-59259-334-7Series ISSN 1064-3745 Series E-ISSN 1940-6029

Detonate

Single-Domain VH Antibody Fragments from a Phage Display Libraryng any given molecular entity (antigen). Antigen recognition is conferred to the antibody by a limited number of hypervariable surface loops, differing in sequence and in length, which are connected to a conserved framework structure.

改革運(yùn)動(dòng)

1064-3745 s step-by-step. Moreover, each protocol supplies a troubleshooting guide containing detailed information on possible problems and hints for pot- tial solutions. Antibody technology is a subject978-1-61737-250-6978-1-59259-334-7Series ISSN 1064-3745 Series E-ISSN 1940-6029